Document Detail


Effects of rosiglitazone on cardiac function in CAPD patients: a tissue Doppler study.
MedLine Citation:
PMID:  19839823     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Insulin resistance was an independent predictor of cardiovascular mortality in uremic patients without diabetes. Rosiglitazone (ROS) improves insulin sensitivity in the liver, muscle, and adipose tissue. We prospectively investigated the effects of ROS on cardiac functions by standard (SDE) and tissue Doppler echocardiography (TDI) in continuous ambulatory peritoneal dialysis (CAPD) patients. METHODS: A total of 24 CAPD patients (13 males, 11 females; mean age 42.2 +/- 14.8 years) were included. Routine blood samples were examined. Left and right ventricular functions were assessed, and myocardial performance index (MPI) was calculated by SDE and TDI at baseline and after 12-month ROS therapy. Left and right atrial volumes were measured and indexed to body surface area. RESULTS: When compared with baseline, after 12 months of ROS treatment, it was shown that early (E) and late (A) diastolic velocities of atrioventricular valves, E/A ratio, mitral E-wave deceleration time (DT), isovolumetric relaxation time (IVRT), and MPI were similar (p > 0.05). Also, no significant changes were detected in LV dimensions, LV mass index, LVEF, LA volume index, or RA volume index measured by SDE before and after ROS therapy (p > 0.05). Left and right ventricular function parameters measured by TDI including Sm, Em, Am, Em/Am ratio, E/Em ratio, and MPI were similar. CONCLUSION: It was found that there was no negative effect of long-term ROS therapy on cardiac functions measured by SDE and TDI in CAPD patients.
Authors:
Ahmet Akcay; Gurkan Acar; Abdullah Sokmen; Gulizar Sokmen; Ekrem Dogan; Hayriye Sayarlioglu; Cagatay Citirik; Mehmet Ali Ucar; Cemal Tuncer
Related Documents :
10982543 - Echocardiographic characterization of cardiomyopathy in friedreich's ataxia with tissue...
19765073 - Association of left atrial strain and strain rate assessed by speckle tracking echocard...
15334573 - Time course of 23na signal intensity after myocardial infarction in humans.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Renal failure     Volume:  31     ISSN:  1525-6049     ISO Abbreviation:  Ren Fail     Publication Date:  2009  
Date Detail:
Created Date:  2009-10-20     Completed Date:  2010-01-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701128     Medline TA:  Ren Fail     Country:  England    
Other Details:
Languages:  eng     Pagination:  464-9     Citation Subset:  IM    
Affiliation:
Faculty of Medicine, Department of Cardiology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey. dr.akcay@yahoo.com.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Flow Velocity
Cohort Studies
Echocardiography, Doppler, Pulsed / methods*
Female
Heart Function Tests
Humans
Kidney Failure, Chronic / diagnosis,  mortality,  therapy
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory / adverse effects,  methods*
Probability
Prognosis
Prospective Studies
Reference Values
Risk Assessment
Survival Analysis
Thiazolidinediones / administration & dosage*
Treatment Outcome
Vasodilator Agents / administration & dosage*
Ventricular Dysfunction, Left / drug therapy*,  mortality,  ultrasonography
Ventricular Dysfunction, Right / drug therapy*,  mortality,  ultrasonography
Chemical
Reg. No./Substance:
0/Thiazolidinediones; 0/Vasodilator Agents; 122320-73-4/rosiglitazone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Markers of tubular and glomerular injury in predicting acute renal injury outcome in thermal burn pa...
Next Document:  Metabolic factors and microinflammatory state promote kidney injury in type 2 diabetes mellitus pati...